
Journal of International Oncology ›› 2024, Vol. 51 ›› Issue (10): 650-654.doi: 10.3760/cma.j.cn371439-20240429-00109
• Reviews • Previous Articles Next Articles
					
													Chen Jie, Xu Hong(
), Chen Yutian
												  
						
						
						
					
				
Received:2024-04-29
															
							
																	Revised:2024-05-16
															
							
															
							
																	Online:2024-10-08
															
							
																	Published:2024-12-04
															
						Contact:
								Xu Hong   
																	E-mail:13301549066@163.com
																					Chen Jie, Xu Hong, Chen Yutian. Role of tumor cell-derived exosomes in the pre-metastatic niche formation in colorectal cancer[J]. Journal of International Oncology, 2024, 51(10): 650-654.
| [1] | 郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2024, 46(3): 221-231. DOI: 10.3760/cma.j.cn112152-20240119-00035. | 
| [2] |  
											 Herath S, Razavi Bazaz S, Monkman J, et al. Circulating tumor cell clusters: insights into tumour dissemination and metastasis[J]. Expert Rev Mol Diagn, 2020, 20(11): 1139-1147. DOI: 10.1080/14737159.2020.1846523. 
																							 pmid: 33140979  | 
										
| [3] |  
											 Doglioni G, Parik S, Fendt SM. Interactions in the (Pre)metastatic niche support metastasis formation[J]. Front Oncol, 2019, 9: 219. DOI: 10.3389/fonc.2019.00219. 
																							 pmid: 31069166  | 
										
| [4] | Titu S, Gata VA, Decea RM, et al. Exosomes in colorectal cancer: from physiology to clinical applications[J]. Int J Mol Sci, 2023, 24(5): 4382. DOI: 10.3390/ijms24054382. | 
| [5] | Liu C, Xia C, Xia C. Biology and function of exosomes in tumor immunotherapy[J]. Biomed Pharmacother, 2023, 169: 115853. DOI: 10.1016/j.biopha.2023.115853. | 
| [6] | Tian Y, Cheng C, Wei Y, et al. The role of exosomes in inflammatory diseases and tumor-related inflammation[J]. Cells, 2022, 11(6): 1005. DOI: 10.3390/cells11061005. | 
| [7] | Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis[J]. Nature, 2015, 527(7578): 329-335. DOI: 10.1038/nature15756. | 
| [8] | Li S, Qu Y, Liu L, et al. Tumour-derived exosomes in liver metastasis: a pandora's box[J]. Cell Prolif, 2023, 56(10): e13452. DOI: 10.1111/cpr.13452. | 
| [9] |  
											 Ji Q, Zhou L, Sui H, et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation[J]. Nat Commun, 2020, 11(1): 1211. DOI: 10.1038/s41467-020-14869-x. 
																							 pmid: 32139701  | 
										
| [10] | Wang C, Tsai S. Regulation of lymphangiogenesis by extracellular vesicles in cancer metastasis[J]. Exp Biol Med (Maywood), 2021, 246(19): 2048-2056. DOI: 10.1177/15353702211021022. | 
| [11] |  
											 Sun B, Zhou Y, Fang Y, et al. Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes[J]. Int J Cancer, 2019, 145(6): 1648-1659. DOI: 10.1002/ijc.32196. 
																							 pmid: 30734278  | 
										
| [12] | Hu H, Yu C, Zhang H, et al. Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2[J]. Int J Biol Macromol, 2019, 132: 470-477. DOI: 10.1016/j.ijbiomac.2019.03.221. | 
| [13] |  
											 He Q, Ye A, Ye W, et al. Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1[J]. Cell Death Dis, 2021, 12(6): 576. DOI: 10.1038/s41419-021-03803-8. 
																							 pmid: 34088891  | 
										
| [14] | Dokhanchi M, Pakravan K, Zareian S, et al. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3[J]. Life Sci, 2021, 285: 119937. DOI: 10.1016/j.lfs.2021.119937. | 
| [15] | Shang A, Wang X, Gu C, et al. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1[J]. Aging (Albany NY), 2020, 12(9): 8352-8371. DOI: 10.18632/aging.103145. | 
| [16] |  
											 Chen C, Liu Y, Liu L, et al. Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway[J]. J Exp Clin Cancer Res, 2023, 42(1): 46. DOI: 10.1186/s13046-023-02619-y. 
																							 pmid: 36793126  | 
										
| [17] |  
											 Hu G, Lin C, Gao K, et al. Exosomal circCOL1A1 promotes angiogenesis via recruiting EIF4A3 protein and activating Smad2/3 pathway in colorectal cancer[J]. Mol Med, 2023, 29(1): 155. DOI: 10.1186/s10020-023-00747-x. 
																							 pmid: 37940881  | 
										
| [18] |  
											 Li Y, Jiang D, Zhang Z, et al. Colorectal cancer cell-secreted exosomal miRNA N-72 promotes tumor angiogenesis by targeting CLDN18[J]. Am J Cancer Res, 2023, 13(8): 3482-3499. 
																							 pmid: 37693144  | 
										
| [19] |  
											 Dou R, Liu K, Yang C, et al. EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer[J]. Clin Transl Med, 2021, 11(12): e595. DOI: 10.1002/ctm2.595. 
																							 pmid: 34936736  | 
										
| [20] |  
											 Jiang K, Chen H, Fang Y, et al. Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness[J]. J Exp Clin Cancer Res, 2021, 40(1): 21. DOI: 10.1186/s13046-020-01816-3. 
																							 pmid: 33413536  | 
										
| [21] | Zhao S, Mi Y, Guan B, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer[J]. J Hematol Oncol, 2020, 13(1): 156. DOI: 10.1186/s13045-020-00991-2. | 
| [22] | Chen C, Yao X, Xu Y, et al. Dahuang zhechong pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche[J]. J Ethnopharmacol, 2019, 238: 111878. DOI: 10.1016/j.jep.2019.111878. | 
| [23] | Liang Z, Liu H, Wang F, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization[J]. Cell Death Dis, 2019, 10(11): 829. DOI: 10.1038/s41419-019-2077-0. | 
| [24] |  
											 Wang D, Wang X, Si M, et al. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages[J]. Cancer Lett, 2020, 474: 36-52. DOI: 10.1016/j.canlet.2020.01.005. 
																							 pmid: 31931030  | 
										
| [25] | Pei W, Wei K, Wu Y, et al. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization[J]. Gene, 2023, 885: 147692. DOI: 10.1016/j.gene.2023.147692. | 
| [26] |  
											 Furumaya C, Martinez-Sanz P, Bouti P, et al. Plasticity in pro- and anti-tumor activity of neutrophils: shifting the balance[J]. Front Immunol, 2020, 11: 2100. DOI: 10.3389/fimmu.2020.02100. 
																							 pmid: 32983165  | 
										
| [27] | Shang A, Gu C, Wang W, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis[J]. Mol Cancer, 2020, 19(1): 117. DOI: 10.1186/s12943-020-01235-0. | 
| [28] | Sun H, Meng Q, Shi C, et al. Hypoxia-inducible exosomes facilitate liver-tropic premetastatic niche in colorectal cancer[J]. Hepatology, 2021, 74(5): 2633-2651. DOI: 10.1002/hep.32009. | 
| [29] |  
											 Huang Y, Luo Y, Ou W, et al. Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC[J]. Cancer Cell Int, 2021, 21(1): 528. DOI: 10.1186/s12935-021-02221-2. 
																							 pmid: 34641864  | 
										
| [30] |  
											 Hu X, Lin Z, Wang Z, et al. Emerging role of PD-L1 modification in cancer immunotherapy[J]. Am J Cancer Res, 2021, 11(8): 3832-3840. 
																							 pmid: 34522452  | 
										
| [31] | Xian D, Niu L, Zeng J, et al. LncRNA KCNQ1OT1 secreted by tumor cell-derived exosomes mediates immune escape in colorectal cancer by regulating PD-L1 ubiquitination via miR-30a-5p/USP22[J]. Front Cell Dev Biol, 2021, 9: 653808. DOI: 10.3389/fcell.2021.653808. | 
| [32] |  
											 Sun W, Cui J, Ge Y, et al. Tumor stem cell-derived exosomal microRNA-17-5p inhibits anti-tumor immunity in colorectal cancer via targeting SPOP and overexpressing PD-L1[J]. Cell Death Discov, 2022, 8(1): 223. DOI: 10.1038/s41420-022-00919-4. 
																							 pmid: 35461336  | 
										
| [33] |  
											 Poggio M, Hu TY, Pai CC, et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory[J]. Cell, 2019, 177(2): 414-427.e13. DOI: 10.1016/j.cell.2019.02.016. 
																							 pmid: 30951669  | 
										
| [34] |  
											 Yuan Z, Li Y, Zhang S, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments[J]. Mol Cancer, 2023, 22(1): 48. DOI: 10.1186/s12943-023-01744-8. 
																							 pmid: 36906534  | 
										
| [35] | Tian F, Wang P, Lin D, et al. Exosome-delivered miR-221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer[J]. Cancer Sci, 2021, 112(9): 3744-3755. DOI: 10.1111/cas.15028. | 
| [36] | Kamerkar S, Leng C, Burenkova O, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity[J]. Sci Adv, 2022, 8(7): eabj7002. DOI: 10.1126/sciadv.abj7002. | 
| [1] | Wei Wei, Cai Zhaoying, Qian Yayun. Effect of Marsdenia tenacissima combined with XELOX solution on disulfide apoptosis in human colorectal cancer HCT116 cells [J]. Journal of International Oncology, 2024, 51(9): 545-555. | 
| [2] | Zhan Haifeng, Wang Wenxue, Geng Jiawei. Research progress in precise molecular targeted therapy for advanced colorectal cancer [J]. Journal of International Oncology, 2024, 51(9): 601-605. | 
| [3] | Li Zhiwei, Zhai Chunbao. Research progress on the anti-cancer effect of traditional Chinese medicine polyphenols on colorectal cancer [J]. Journal of International Oncology, 2024, 51(8): 526-531. | 
| [4] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. | 
| [5] | Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375. | 
| [6] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. | 
| [7] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285. | 
| [8] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297. | 
| [9] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong. Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer [J]. Journal of International Oncology, 2024, 51(4): 235-238. | 
| [10] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174. | 
| [11] | Liu Bohan, Huang Junxing. Research progress of liquid biopsy technology in esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2024, 51(2): 105-108. | 
| [12] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118. | 
| [13] | He Peipei, Yang Chaofeng, Li Yang. Research status and prospect of tumor microenvironment and ablation therapy for liver cancer [J]. Journal of International Oncology, 2024, 51(10): 655-659. | 
| [14] | Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie. Research progress of myeloid-derived suppressor cells in tumor angiogenesis [J]. Journal of International Oncology, 2024, 51(1): 50-54. | 
| [15] | Gu Huayan, Zhu Teng, Guo Guilong. Breast microbiota and breast cancer: present and future [J]. Journal of International Oncology, 2024, 51(1): 55-58. | 
| Viewed | ||||||
| 
										Full text | 
									
										 | 
								|||||
| 
										Abstract | 
									
										 | 
								|||||